Research
Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-α inhibitors or nonbiologic agents: a cohort study
Rishi J. Desai, Joshua J. Gagne, Joyce Lii, Jun Liu, Sonia Friedman and Seoyoung C. Kim
CMAJ November 27, 2017 189 (47) E1438-E1447; DOI: https://doi.org/10.1503/cmaj.161485
Rishi J. Desai
Divisions of Pharmacoepidemiology and Pharmacoeconomics (Desai, Gagne, Lii, Liu, Kim), of Gastroenterology (Friedman) and of Rheumatology (Kim), Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.
MS PhDJoshua J. Gagne
Divisions of Pharmacoepidemiology and Pharmacoeconomics (Desai, Gagne, Lii, Liu, Kim), of Gastroenterology (Friedman) and of Rheumatology (Kim), Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.
PharmD ScDJoyce Lii
Divisions of Pharmacoepidemiology and Pharmacoeconomics (Desai, Gagne, Lii, Liu, Kim), of Gastroenterology (Friedman) and of Rheumatology (Kim), Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.
MS MAJun Liu
Divisions of Pharmacoepidemiology and Pharmacoeconomics (Desai, Gagne, Lii, Liu, Kim), of Gastroenterology (Friedman) and of Rheumatology (Kim), Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.
MD MPHSonia Friedman
Divisions of Pharmacoepidemiology and Pharmacoeconomics (Desai, Gagne, Lii, Liu, Kim), of Gastroenterology (Friedman) and of Rheumatology (Kim), Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.
MDSeoyoung C. Kim
Divisions of Pharmacoepidemiology and Pharmacoeconomics (Desai, Gagne, Lii, Liu, Kim), of Gastroenterology (Friedman) and of Rheumatology (Kim), Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.
MD ScD
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-α inhibitors or nonbiologic agents: a cohort study
Rishi J. Desai, Joshua J. Gagne, Joyce Lii, Jun Liu, Sonia Friedman, Seoyoung C. Kim
CMAJ Nov 2017, 189 (47) E1438-E1447; DOI: 10.1503/cmaj.161485
Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-α inhibitors or nonbiologic agents: a cohort study
Rishi J. Desai, Joshua J. Gagne, Joyce Lii, Jun Liu, Sonia Friedman, Seoyoung C. Kim
CMAJ Nov 2017, 189 (47) E1438-E1447; DOI: 10.1503/cmaj.161485